0
0
11/11/23 at 8:14pm
Organization
Medscape
Author
Ted Bosworth
31 words
0
Comments
The randomized ORBITA-2 trial, unlike the preceding ORBITA trial, shows benefit for percutaneous coronary intervention in patients with stable angina.
You are the first to view
https://www.medscape.com/viewarticle/998375
Create an account
or login to join the discussion